Immunostaining of Kir2.3 and Kir4.1 predominantly labeled the nucleus of glioblastoma cells (Figure 1), while expression in normal astrocytes was diffuse over the plasma membrane [23]. Here, KCNJ4 is linked to glioblastoma.